In total, we identified 2 candidate biomarkers TRAIL and IL-10 that had significantly different levels between individuals with AG PCa and benign disease and further evaluated them using Luminex single cytokine immunoassays in the 288 sera. The gene discussed is TNFSF10; the disease is posterior cortical atrophy.